Kestra Medical Technologies, Ltd.
Kestra Medical Technologies, Ltd. (KMTS) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
kmts · pe ratio · data through Apr 30, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Kestra Medical Technologies, Ltd. (KMTS) measures how much investors pay for each dollar of the company's trailing earnings. KMTS's current PE ratio of N/A is calculated by dividing its stock price of $20.31 by its TTM earnings per share of -$2.74.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-04-30
PE Ratio History
2020 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Instruments & Supplies · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Kestra Medical Technologies, Ltd.You KMTS | $1.2B | N/A | — | -$2.74 |
 Azenta, Inc. AZTA | $1.1B | N/A | — | -$1.22 |
 BioLife Solutions, Inc. BLFS | $1.3B | N/A | — | -$0.25 |
 Evotec SE EVO | $1.0B | N/A | — | -$0.28 |
 Neogen Corporation NEOG | $2.0B | N/A | — | -$5.03 |
 NovoCure Limited NVCR | $2.0B | N/A | — | -$1.22 |
 Precigen, Inc. PGEN | $1.1B | N/A | — | -$0.82 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-04-30Latest FY2025 | — | $-2.30 | — | |
2024-04-30 FY2024 | — | $-1.90 | — | |
2023-04-30 FY2023 | — | $-1.70 | — | |
2021-04-30 FY2021 | — | $-0.69 | — | |
2020-04-30 FY2020 | — | $-0.59 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Kestra Medical Technologies, Ltd. (KMTS) measures how much investors pay for each dollar of the company's trailing earnings. KMTS's current PE ratio of N/A is calculated by dividing its stock price of $20.31 by its TTM earnings per share of -$2.74.
Frequently asked questions
KMTS pe ratio · 6 questionsKMTS's current PE ratio is N/A as of 2026-06-08, based on a stock price of $20.31 and TTM EPS of -$2.74. Data sourced from Financial Modeling Prep via KMTS's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Kestra Medical Technologies, Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08